RxDoctor Payments Data

John Callahan, MD

Hand Surgery · Amherst, NYNPI 1952338048

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Sonex Health, Inc. at 39.4% of the total. Reporting peaked in 2023 at $1,681 and has fallen 78.5% since, to $362 in 2025.

$4,066in general payments, 2019–2025

Across 50 payments — averaging $81.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sonex Health, Inc.$2K
  • Prodigy Surgical Distribution, Inc.$1K
  • Endo Pharmaceuticals Inc.$329
  • Stryker$240
  • Skeletal Dynamics Inc$184
  • Integra Lifesciences Corporation$171
  • plus $455 from 9 others
$240,325in research payments, 2019–2025

Across 3 payments — averaging $80,108 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sonex Health, Inc.$240K

What the payments were for

  • Speaking & faculty fees$501%
  • Travel & lodging$97724%
  • Food & beverage$1,86946%
  • Education$1,00025%
  • Other$1714%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,066 in reported general payments places this provider in the 60th percentile of 178 hand surgery providers in New York.

See all hand surgery providers in New York

Medicare billing

Part B allowed, 2024
$109,004
Medicare patients
275
Services billed
1,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen75$313
Methylprednisolone15$189
Cephalexin22$114
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$38

Paid to pharmacies, not to this prescriber.

Other hand surgery in Amherst

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →